This site uses cookies to ensure the best viewing experience for our readers.
Israeli Tech Companies Raised $2.32 Billion in Q2 2019, Report Says

Israeli Tech Companies Raised $2.32 Billion in Q2 2019, Report Says

In the first six months of 2019, Israeli tech companies raised $3.87 billion in 254 deals, more than 60% of the total investments made in 2018, according to a joint report by IVC and the Israel office of international law firm Zysman, Aharoni, Gayer & Co.

Hagar Ravet | 13:32, 17.07.19
Israeli tech companies have raised $2.32 billion in the second quarter of 2019, the highest sum raised in a single quarter since 2013, according to a joint report released Wednesday by Tel Aviv-based research firm IVC Research Center and the Israel office of international law firm Zysman, Aharoni, Gayer & Co. (ZAG-S&W).

For daily updates, subscribe to our newsletter by clicking here.

In the first six months of 2019, Israeli tech companies raised $3.87 billion across 254 deals, more than 60% of the total investments made in 2018, according to the report.

Tel Aviv. Photo: Shutterstock Tel Aviv. Photo: Shutterstock Tel Aviv. Photo: Shutterstock
Of the funds raised in this year’s second quarter, 78% were venture capital-based investments, which amounted to $1.81 billion across 73 deals. In the first quarter of 2019, 75 venture capital-based investments totaled $1.34 billion.

The median deal amount for Q2 was $5.5 million, compared with $5 million in the same period last year and $6 million in Q1 2019.

Late-stage companies raised record amounts in the second quarter of 2019 but for mid-stage companies funding was lower than in recent years, Shmulik Zysman, a managing partner at ZAG-S&W, said in a statement.

Related stories

“The Q2 figures show that most early-stage companies are struggling to access investment capital,” Marianna Shapira, a research director at IVC, said. “This discrepancy might be a cause for concern about the future of seed ventures in Israel,” she added.

Information technology and software companies raised the highest sum of $1.02 billion in 49 deals in Q2, while life sciences companies came in second with $263 million in 27 deals.
share on facebook share on twitter share on linkedin share on whatsapp share on mail

TAGS